spacer
The Healthcare Sales & Marketing Network celebrates 25 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  CoStar 

 HSMN NewsFeed - 14 Dec 2009
FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults
Biopharmaceuticals FDA
 HSMN NewsFeed - 4 Dec 2009
FDA Approves Lilly's Zyprexa for Two Adolescent Indications
Biopharmaceuticals FDA
 HSMN NewsFeed - 2 Feb 2009
Molecular Insight Pharmaceuticals Announces Board and Senior Management Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Jan 2009
Lilly Resolves Investigations of Past Zyprexa Marketing and Promotional Practices
Biopharmaceuticals
 HSMN NewsFeed - 7 Oct 2008
Eli Lilly and Company Resolves Investigation Involving Numerous States
Biopharmaceuticals
 HSMN NewsFeed - 26 Sep 2008
CHMP Recommends Approval of Olanzapine Long-acting Injection for Maintenance Treatment of Schizophrenia in Europe
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 12 Mar 2008
Statement from Eli Lilly and Company: Response to Connecticut Attorney General News Release
Biopharmaceuticals
 HSMN NewsFeed - 28 Feb 2008
FDA Issues Not-Approvable Letter for Lilly's Zyprexa(R) Long-Acting Injection (LAI) for Schizophrenia Treatment
Biopharmaceuticals FDA
 HSMN NewsFeed - 6 Feb 2008
FDA Advisory Committee Supports Efficacy and Safety of Zyprexa(R) Long-Acting Injection (LAI) for Schizophrenia Treatment
Biopharmaceuticals FDA
 HSMN NewsFeed - 5 Oct 2007
Lilly Announces Updates to the Zyprexa and Symbyax U.S. Labels
Biopharmaceuticals
 HSMN NewsFeed - 17 Sep 2007
Angiotech reaches agreement with Johnson & Johnson to settle outstanding patent litigation
Devices Litigation Interventional Cardiology
 HSMN NewsFeed - 7 Sep 2007
Statement of Eli Lilly and Company on Dr. David Egilman Settlement
Biopharmaceuticals Litigation
 HSMN NewsFeed - 7 May 2007
Conor Medsystems, LLC Reports COSTAR II Pivotal Drug-Eluting Stent Trial Conclusions
Devices Interventional Cardiology
 HSMN NewsFeed - 23 Feb 2007
Conor Medsystems to Present COSTAR II Data at EuroPCR
Devices Interventional Cardiology
 HSMN NewsFeed - 14 Feb 2007
Eli Lilly and Company Statement: Judge Grants Lilly's Request for a Permanent Injunction Involving Misleading Selection of Illegally Leaked Lilly Documents
Biopharmaceuticals Litigation
 HSMN NewsFeed - 1 Feb 2007
Johnson & Johnson Completes Acquisition of Conor Medsystems, Inc.
Devices Interventional Cardiology Mergers & Acquisitions
 HSMN NewsFeed - 17 Jan 2007
Conor Medsystems Comments on Netherlands Court Decision on Angiotech Patent
Devices Interventional Cardiology Litigation
 HSMN NewsFeed - 17 Jan 2007
Angiotech wins patent infringement case in the Netherlands
Devices Interventional Cardiology Litigation
 HSMN NewsFeed - 17 Jan 2007
Boston Scientific and Angiotech Win Patent Infringement Case Against Conor in the Netherlands
Devices Interventional Cardiology Litigation
 HSMN NewsFeed - 4 Jan 2007
Eli Lilly and Company Statement Regarding Today's New York Times Article - January 4, 2007
Biopharmaceuticals
 HSMN NewsFeed - 4 Jan 2007
Lilly and Plaintiffs' Attorneys Enter Into Agreements to Settle Zyprexa(R) Product Liability Litigation
Biopharmaceuticals Litigation
 HSMN NewsFeed - 1 Dec 2006
Lilly Responds to the Cost-Effectiveness Analysis of the CATIE Schizophrenia Trial
Biopharmaceuticals
 HSMN NewsFeed - 17 Nov 2006
SurModics Provides Additional Information on its License Agreement with Conor Medsystems
Devices Interventional Cardiology Licensing
 HSMN NewsFeed - 16 Nov 2006
Johnson & Johnson Announces Definitive Agreement to Acquire Conor Medsystems, Inc.
Devices Interventional Cardiology Mergers & Acquisitions
 HSMN NewsFeed - 5 Oct 2006
Conor Medsystems Receives Approval for One-Year Shelf Life for CoStar(R) Stent in the European Union
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 5 Sep 2006
Conor Medsystems Announces Two-Year Follow-Up Data from EuroSTAR Pivotal Study
Devices Interventional Cardiology
 HSMN NewsFeed - 18 May 2006
Conor Medsystems Announces First Patient Treated with Dual-Drug Coronary Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 11 May 2006
Conor Medsystems Initiates RAPID Clinical Study for First Pimecrolimus Drug-Eluting Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 4 May 2006
Boston Scientific Sues Conor Medsystems Ireland Ltd.
Devices Interventional Cardiology Litigation
 HSMN NewsFeed - 20 Apr 2006
Conor Medsystems Completes Enrollment of COSTAR II Pivotal Randomized Drug-Eluting Stent Trial
Devices Interventional Cardiology
 HSMN NewsFeed - 16 Mar 2006
Conor Medsystems Licenses Pimecrolimus From Novartis for Use in Next-Generation Reservoir-Based Drug-Eluting Stents
Devices Licensing Interventional Cardiology
 HSMN NewsFeed - 17 Feb 2006
Conor Medsystems Receives CE Mark for CoStar(TM) Drug-Eluting Stent
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 9 Jan 2006
Micrus Endovascular and BIOTRONIK AG Sign Development and Distribution Agreement
Devices Interventional Distribution
Return to NewsFeed  

 Additional items found! 28

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 28 additional stories matching:
CoStar
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.